AMGN) — Amgen Inc. (NASDAQ

Jackson Grant Investment Advisers Inc. now owns 641 shares of the medical research company's stock worth $110,000 after buying an additional 5 shares during the last quarter. Pinnacle Holdings Llc who had been investing in Mutualfirst Financial for a number of months, seems to be less bullish one the $280.43 million market cap company. In the last quarter, insiders sold 7,050 shares of company stock valued at $1,225,765. (NYSE:AIG) has risen 8.59% since January 13, 2017 and is uptrending. It has outperformed by 10.18% the S&P500.

Sawgrass Asset Management Llc increased its stake in Amgen Inc Com (AMGN) by 5348.25% based on its latest 2017Q3 regulatory filing with the SEC. This buyback authorization authorizes the medical research company to buy shares of its stock through open market purchases. The institutional investor held 4,346 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $810,000, down from 44,132 at the end of the previous reported quarter. The company had revenue of $5.77 billion for the quarter, compared to analysts' expectations of $5.75 billion. The stock decreased 0.29% or $0.18 during the last trading session, reaching $60.97. The medical research company reported $3.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $0.16. Amgen Inc. (NASDAQ:AMGN) has risen 5.27% since January 12, 2017 and is uptrending. It has underperformed by 34.90% the S&P500. The company has a market capitalization of $123.59 billion, a price-to-earnings ratio of 16.35 and a beta of 1.15. During the same quarter in the previous year, the business earned $3.02 EPS. AMGN's profit will be $2.19B for 15.36 P/E if the $3.02 EPS becomes a reality. Bridgeway Management reported 145,000 shares.

Liberty Mutual Group Asset Management Inc decreased Amgen Inc (AMGN) stake by 35.43% reported in 2017Q3 SEC filing.

Tirschwell & Loewy Inc decreased its stake in Amgen Inc. On Thursday, August 11 the stock rating was maintained by Deutsche Bank with "Hold".

Investors sentiment increased to 0.7 in 2017 Q3. Its down 0.16, from 1.15 in 2017Q2. 116 funds opened positions while 640 raised stakes. Clarivest Asset Llc holds 0% or 14 shares in its portfolio. Ahl Ptnrs Llp stated it has 10,230 shares. Hl Fincl Svcs Limited Co holds 0.19% of its portfolio in Amgen Inc. Modera Wealth Ltd Liability Company invested 1.09% of its portfolio in Amgen Inc. (NYSE:BRO) for 13,662 shares. About 345,471 shares traded. Weiss Multi stated it has 0.37% in Brown & Brown, Inc. Avenir holds 1.62% or 122,432 shares in its portfolio. There has been an observed change of -0.78% in the ownership of the shares in the past six months. Bailard has invested 0.07% of its portfolio in Amgen Inc. Mogy Joel R Invest Counsel holds 6,790 shares or 0.21% of its portfolio. The legal version of this story can be viewed at Geode Mgmt Lc invested in 412,487 shares. DekaBank Deutsche Girozentrale now owns 883,579 shares of the medical research company's stock valued at $152,927,000 after buying an additional 24,219 shares during the period. Therefore 77% are positive. Jefferies maintained the stock with "Buy" rating in Thursday, September 28 report. (NASDAQ:RXDX) on Friday, December 22 to "Hold" rating. The firm has "Buy" rating by Mizuho given on Sunday, October 29. The company was maintained on Thursday, August 17 by Keefe Bruyette & Woods. Oppenheimer maintained the stock with "Buy" rating in Friday, July 28 report. The company was upgraded on Monday, September 7 by UBS. As per Wednesday, December 7, the company rating was upgraded by Credit Suisse. Amgen Inc. had 73 analyst reports since August 3, 2015 according to SRatingsIntel. One equities research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and ten have assigned a buy rating to the company's stock.

Ratings analysis reveals 46% of Amgen Inc.'s analysts are positive. Amgen Inc. had 74 analyst reports since August 3, 2015 according to SRatingsIntel.

In recent action, Amgen Inc. Mizuho reiterated a "buy" rating and issued a $198.00 price target on shares of Amgen in a research note on Friday, October 6th. The brokerage now has a "buy" rating on the medical research company's stock. (NASDAQ:AMGN) was sold by Harper Sean E on Monday, October 9. Leerink Swann restated a "market perform" rating and issued a $163.00 target price (down from $193.00) on shares of Amgen in a research report on Friday, October 28th. Morgan Stanley has "Overweight" rating and $193 target. Oppenheimer maintained it with "Buy" rating and $203.0 target in Wednesday, August 16 report. As per Thursday, February 25, the company rating was initiated by Citigroup. Morgan Stanley maintained Amgen Inc. Cowen & Co has "Market Perform" rating and $125.0 target. The firm has "Hold" rating by SunTrust given on Tuesday, December 26.

Since October 9, 2017, it had 0 insider purchases, and 2 insider sales for $553,240 activity.

Amgen earned a news sentiment score of 0.24 on Accern's scale. Its up 0.66, from 1.41 in 2017Q2. It worsened, as 58 investors sold AMGN shares while 511 reduced holdings. The medical research company reported $3.27 EPS for the quarter, beating the consensus estimate of $3.11 by $0.16. Partnervest Advisory Services Lc reported 0.32% stake. 398,240 are owned by Nomura Asset Ltd. Salem Investment Counselors reported 0% stake. Broadleaf Partners LLC purchased a new stake in shares of Amgen during the fourth quarter worth about $2,429,000. That suggests something of the likelihood of a short squeeze in shares of AMGN. Drexel Hamilton maintained Apple Inc. (NASDAQ:AMGN) for 3,250 shares. Charter Trust invested in 0.25% or 10,885 shares. Waverton Investment Management Ltd now owns 12,504 shares of the medical research company's stock valued at $1,902,000 after buying an additional 510 shares during the period. First Quadrant LP Ca reported 991,207 shares. Aspen Management owns 7,155 shares. (NASDAQ:AMGN) for 39,400 shares. Ra Cap Management Ltd Llc has invested 4.58% in Ignyta, Inc. (NASDAQ:AMGN). Timber Creek Mgmt Ltd Liability reported 18,387 shares stake. Price T Rowe Md reported 359,359 shares.

Laffer Investments, which manages about $614.32M and $378.86B US Long portfolio, upped its stake in Ishares 1 (CSJ) by 54 shares to 3,288 shares, valued at $346.39 million in 2017Q3, according to the filing. Appleton Partners Inc. MA boosted its holdings in shares of Amgen by 8.9% during the fourth quarter.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Latest news

Google reportedly plans to revamp its store with Assistant as the focus
The technology was packed into a variety of smart home products , ranging from speakers and radios through to lamps and vacuum ... More and more companies are adopting virtual assistants in all sorts of devices to make them compelling prospects for customers.

Hawaii officials say 'ballistic missile threat' emergency alert was mistake
Command said on Saturday there was no threat to Hawaii , which is a chain of islands in the Pacific Ocean, and is home to the U.S. What happened today is totally inexcusable. "If this was for real, what do we have to say for our whole defense system".

DISH Network (DISH) Receiving Somewhat Favorable Media Coverage, Analysis Shows
The total amount of shares outstanding is 467.87 million, giving the company a market capitalization of about 22.88 billion. The stock of DISH Network Corporation (NASDAQ: DISH ) has "Outperform" rating given on Monday, August 10 by FBR Capital.

Crowds gather for Virginia inauguration on chilly Saturday
He is also the first Virginia Military Institute graduate to become governor since Westmoreland Davis was inaugurated in 1918. Lieutenant Governor Justin Fairfax was also sworn in at Capitol Square on Saturday, in addition to Governor Ralph Northam.

Hot Stock for Investors: Amicus Therapeutics, Inc. (FOLD)
The stock, as of last close, traded 175.35% away to its 52 week low and was at a distance of -15.90% from its 52 week high. Amicus Therapeutics (NASDAQ:FOLD) last released its quarterly earnings data on Wednesday, November 8th.

Other news